Prescription Benefits Management

Walgreen CFO: better off without Express Scripts

NEW YORK (Reuters) - Walgreen Co Chief Financial Officer Wade Miquelon said on Thursday that the drugstore chain's decision to end its agreement with pharmacy benefits management (PBM) company Express Scripts Inc was not a bargaining tactic but a "principled stand."
 

Walgreen balks, walks away from Express Scripts

CHICAGO/NEW YORK (Reuters) - Walgreen Co <WAG.N> will stop filling prescriptions for people covered by drug benefits manager Express Scripts Inc <ESRX.O> at the end of 2011 after failing to agree on new contract terms, walking away from a deal worth more than $5 billion in annual sales.
 

Walgreen says Express Scripts deal to end

CHICAGO (Reuters) - Drugstore chain operator Walgreen Co said it will stop filling prescriptions for people covered by drug benefits manager Express Scripts Inc at the end of the year after failing to agree on a new contract.
 

Material world lifts stocks; Dow, S&P off for fourth week

NEW YORK (Reuters) - The Dow and S&P 500 closed out their fourth week of losses with a small gain on Friday, but only with the help of a weaker dollar boosting metals prices and basic materials stocks.
 

CVS ex-CEO takes home over $120 million for 2010

BANGALORE (Reuters) - CVS Caremark Corp's <CVS.N> former Chief Executive, Thomas Ryan, who recently retired after a 12-year tenure as CEO of the U.S. drugstore chain, took home more than $120 million in 2010.
 

Wedgewood's Rolfe see Apple and Google as winners

BOSTON (Reuters) - The latest headlines about Google and Apple pit the companies against each other in a heated battle for smartphone supremacy, but both will end up winners, according to fund manager David Rolfe.
 

CVS to buy Universal's Medicare unit for $1.25 billion

NEW YORK (Reuters) - CVS Caremark, No. 2 U.S. drugstore chain, agreed to buy Universal American's Medicare prescription drug business for about $1.25 billion to expand in a growing segment of the pharmacy benefit market.
 

CVS to buy Universal's Medicare unit for $1.25 billion

NEW YORK (Reuters) - CVS Caremark, No. 2 U.S. drugstore chain, agreed to buy Universal American's Medicare prescription drug business for about $1.25 billion to expand in a growing segment of the pharmacy benefit market.
 

CVS to buy Medicare business of Universal American

CVS to acquire Universal American's Medicare business for $1.25 billion. CVS Caremark Corp. says it will pay $1.25 billion to Universal American Corp. for its Medicare prescription drug services unit.
 

CVS to buy Medicare business of Universal American

CVS to acquire Universal American's Medicare business for $1.25 billion. CVS Caremark Corp. says it will pay $1.25 billion to Universal American Corp. for its Medicare prescription drug services unit.
 

CVS to buy Medicare business of Universal American

CVS Caremark Corp. says it will pay $1.25 billion to Universal American Corp. for its Medicare prescription drug services unit.
 

Medco buys consulting firm Total Healthcare

Medco Health Solutions Inc. says it bought Total Healthcare Group of London, a consulting firm that serves clients in the biotechnology industry. Terms were not disclosed.
 

CVS hires Wal-Mart ex-retail exec, Wal-Mart sues

NEW YORK/WILMINGTON, Delaware (Reuters) - CVS Caremark Corp <CVS.N> named a recent Wal-Mart Stores Inc <WMT.N> executive as the new president of its retail pharmacy business, prompting Wal-Mart to sue over an alleged breach of a noncompete agreement.
 

Sigma-Aldrich reshuffles after death of its leader

Biochemical company Sigma-Aldrich reshuffles leadership after weekend death of CEO, chairman. Billion-dollar biochemicals interest Sigma-Aldrich Corp. introduced its shuffled executive staff Monday as it mourned the weekend death of its leader, who spent more than three decades with the company.
 

Summary Box: CVS Caremark 3Q profit, revenue slip

Summary Box: CVS profit and revenue decline on 2009 contract losses for Caremark division. A look inside CVS Caremark Corp.'s third-quarter results.
 

CVS Caremark profit falls 21 percent in 3Q

CVS Caremark reports lower 3rd-quarter profit on lost pharmacy benefit business. CVS Caremark Corp. reported a 21 percent drop in third-quarter profit Wednesday as its pharmacy benefit unit continued losing business from previously canceled contracts.
 

WellPoint and Aetna beat on profit, raise 2010 views

NEW YORK (Reuters) - WellPoint Inc <WLP.N> and Aetna Inc <AET.N> raised their profit forecasts for the year as members avoided doctor visits or delayed care to save money, and the large U.S. health insurers should see an improved political environment for their business under the new Congress.
 

CVS Caremark profit falls 21 percent in 3Q

CVS Caremark reports lower 3rd-quarter profit on lost pharmacy benefit business. CVS Caremark Corp. reported a 21 percent drop in third-quarter profit Wednesday as its pharmacy benefit unit continued losing business from previously canceled contracts.
 

CVS Caremark profit falls 21 percent in 3Q

CVS Caremark Corp. reported a 21 percent drop in third-quarter profit Wednesday as its pharmacy benefit unit continued losing business from previously canceled contracts.
 

Medco sees generic drug gains to 2020, shares jump

NEW YORK (Reuters) - Medco Health Solutions Inc <MHS.N> projected earnings would rise as much as 17 percent next year despite challenges and painted a rosy picture for the next decade, sending shares up more than 10 percent on Tuesday.